Clinical Trial Update: Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing cardio-renal effects of SGLT2 inhibitors in lupus nephritis patients; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Mansoura University | Conditions: SLE, Lupus Nephritis | Phase 4 | Status: COMPLETED | Results posted: 2025-04-16